Navan, Inc.
NAVN Nasdaq Services-Prepackaged Software Financials FY2024βFY2026
What Navan, Inc. does
No business description yet.
- Legal name
- Navan, Inc.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K Β· Apr 2, 2026
- Accession Β· CIK
- 0001628280-26-023250
0001639723
Revenue and margins
Navan, Inc. had $702M of revenue in fiscal 2026, up 30.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $32.8M in fiscal 2026, 4.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Navan, Inc. returned β to shareholders in fiscal 2026. The diluted share count rose 116.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Navan, Inc. can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | $166M | $158M | $741M |
| Debt incl. finance leases | β | $618M | $125M |
| Debt / equity | β | β | 0.1x |
| Interest coverage | β3.9x | β1.4x | β3.8x |
| Current ratio | β | 1.5x | 4.1x |
| Quick ratio | β | 1.5x | 4.1x |
| Total assets | β | $1.1B | $1.7B |
| Total liabilities | β | $970M | $501M |
| Shareholders' equity | β$1.1B | β$1.2B | $1.2B |
| Net debt (β = net cash) | β | $460M | β$616M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 9 |
| Accruals ratio | β | β12.1% | β30.9% |
| Altman Z'' | β | β5.35 | 1.70 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $402M | $537M | $702M |
| Provision for credit losses | $8.7M | $5.9M | $9.1M |
| Gross profit | $240M | $367M | $500M |
| Research and development | $132M | $122M | $151M |
| Operating income | β$246M | β$108M | β$197M |
| Interest expense | $63.3M | $76.0M | $51.3M |
| Pretax income | β$326M | β$172M | β$396M |
| Income tax | $5.4M | $9.6M | $2.1M |
| Net income | β$332M | β$181M | β$398M |
| Diluted EPS | β$7.44 | β$4.00 | β$4.07 |
| Diluted shares | 0.04B | 0.05B | 0.10B |
| Cash flow | |||
| Cash from operations | β$166M | β$50.4M | $33.7M |
| Capital expenditure | $0.6M | $1.0M | $0.9M |
| Free cash flow | β$167M | β$51.4M | $32.8M |
| Depreciation and amortization | $26.9M | $24.9M | $60.2M |
| Stock-based compensation | $75.9M | $77.0M | $182M |
| Acquisitions | $7.0M | $3.9M | $0.0M |
| Balance sheet | |||
| Cash and short-term investments | $166M | $158M | $741M |
| Total debt | β | $618M | $125M |
| Current assets | β | $689M | $1.3B |
| Current liabilities | β | $446M | $321M |
| Property and equipment, net | β | $29.5M | $35.0M |
| Goodwill | $221M | $220M | $241M |
| Intangible assets | β | $55.6M | $19.3M |
| Total assets | β | $1.1B | $1.7B |
| Total liabilities | β | $970M | $501M |
| Preferred stock | β | $0.0M | $0.0M |
| Shareholders' equity | β$1.1B | β$1.2B | $1.2B |
| Margins | |||
| Gross margin | 59.6% | 68.4% | 71.3% |
| Operating margin | β61.2% | β20.1% | β28.0% |
| EBITDA margin | β54.6% | β15.4% | β19.5% |
| Net margin | β82.4% | β33.7% | β56.7% |
| FCF margin | β41.5% | β9.6% | 4.7% |
| Returns | |||
| Return on capital | β | β | β26.3% |
| Return on capital employed | β | β16.9% | β14.2% |
| Return on equity | β | β | β3,761.7% |
| Return on assets | β | β16.7% | β28.5% |
| Return on tangible equity | β | β | β42.0% |
| Growth | |||
| Revenue growth | β | 33.5% | 30.8% |
| Share count change | β | 1.5% | 116.0% |
| Financial health | |||
| Debt / equity | β | β | 0.1x |
| Interest coverage | β3.9x | β1.4x | β3.8x |
| Current ratio | β | 1.5x | 4.1x |
| Quick ratio | β | 1.5x | 4.1x |
| Capital allocation | |||
| Capex / revenue | 0.1% | 0.2% | 0.1% |
| Stock comp / revenue | 18.9% | 14.3% | 25.9% |
| Quality scores | |||
| Piotroski F-score | β | β | 5.0 |
| Altman Z'' | β | β5.3 | 1.7 |
| Accruals ratio | β | β12.1% | β30.9% |
Source: SEC EDGAR XBRL filings (CIK 0001639723). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.